Company Founded
Series A Fundraising
POC Animal
Patents Filed
Series B Fundraising
Founded January
Private investors
Primarily European
Previous Raptor* investors
POC in dogs
Highly translatable to humans
Additional studies underway
2 patents pending
2017
2018
- CMC
- Phase 2
*Raptor Pharmaceuticals, Inc.